Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases (eBook)

Christopher L. Cioffi (Herausgeber)

eBook Download: PDF
2020 | 1st ed. 2020
IX, 272 Seiten
Springer International Publishing (Verlag)
978-3-030-56619-7 (ISBN)

Lese- und Medienproben

Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases -
Systemvoraussetzungen
309,23 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen

This book reviews the current state of ocular drug therapy and future therapeutic opportunities for a wide variety of conditions, including Age-related Macular Degeneration, Diabetic Retinopathy and Macular Edema, Glaucoma, and Inherited Retinal Diseases.

Retinal diseases are major contributors to moderate or severe vision impairment in adults aged 50 years and older. The respective patient populations for many of these indications is expected to significantly increase as the world population continues to grow older. An improved understanding of the etiological underpinnings of ocular degenerative diseases over the past decade has significantly bolstered ophthalmic drug discovery.

In this volume, contributions from leading experts explore the unique challenges faced for ocular drug discovery and delivery providing the reader with detailed information on ocular pharmacokinetics, in vitro, ex vivo and in vivo models for retinal disease pathology and emerging gene therapy treatments. The book is intended for all researchers and clinicians who wish to increase their knowledge on the latest findings in ocular drug therapy.



Christopher L. Cioffi is an Assistant Professor of Medicinal Chemistry in the Department of Basic and Clinical Sciences and the Department of Pharmaceutical Sciences at Albany College of Pharmacy and Health Sciences. Christopher received his doctorate in Organic Chemistry from Rensselaer Polytechnic Institute in 2000. He subsequently conducted a 16-year career as a medicinal chemist at Albany Molecular Research, Inc. where he led numerous medicinal chemistry teams and made significant drug design contributions to programs that advanced drug candidates into pre-clinical development and clinical trials. His work has spanned several therapeutic areas that include cardiovascular, gastrointestinal, CNS, and ophthalmic indications. Notably, Christopher has contributed to the discovery of Eli Lilly's cholesteryl ester transfer protein inhibitor evacetrapib, which progressed to Phase III clinical trials for dyslipidemia. Additionally, he has co-discovered the 5-HT3 partial agonist SMP-100 (SciMount Therapeutics) to be studied for efficacy against IBS-D and the retinol binding protein 4 antagonist tinlarebant (Belite Bio) for the treatment of Stargardt disease. Tinlarebant has completed Phase I clinical trials and Phase II trials with Stargardt disease patients are expected to commence in 2020. SMP-100 is currently undergoing Phase I clinical trials. Christopher joined Albany College of Pharmacy and Health Sciences in 2016 and is engaged drug discovery projects focused in the areas of atrophic age-related macular degeneration and chronic pain.
Erscheint lt. Verlag 23.9.2020
Reihe/Serie Topics in Medicinal Chemistry
Topics in Medicinal Chemistry
Zusatzinfo IX, 272 p. 1 illus.
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Augenheilkunde
Studium 2. Studienabschnitt (Klinik) Humangenetik
Naturwissenschaften Chemie Physikalische Chemie
Schlagworte Current Ocular Drug Discovery • Diabetic macular edema • Diabetic retinopathy • gene therapy • glaucoma • macular degeneration • Ocular pharmacokinetics • retinal diseases • Stargardt disease
ISBN-10 3-030-56619-6 / 3030566196
ISBN-13 978-3-030-56619-7 / 9783030566197
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 6,2 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich

von Berit Hackenberg; Anja Hohmann

eBook Download (2023)
Urban & Fischer Verlag - Lehrbücher
26,99
Leber, Gallenwege und Pankreas

von Andrea Tannapfel; Günter Klöppel

eBook Download (2020)
Springer Berlin Heidelberg (Verlag)
299,00